# FDA Inspection 803892 - Alxigna, Inc. - October 16, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/alxigna-inc/96ff4f6d-d4aa-4e31-a6d5-8278b849170b
Source feed: FDA_Inspections

> FDA Inspection 803892 for Alxigna, Inc. on October 16, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 803892
- Company Name: Alxigna, Inc.
- Inspection Date: 2012-10-16
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1028740 - 2017-10-11](https://www.globalkeysolutions.net/records/fda_inspections/alxigna-inc/874adc63-4081-443c-83a4-e0e1f694758a)
- [FDA Inspection 803892 - 2012-10-16](https://www.globalkeysolutions.net/records/fda_inspections/alxigna-inc/3bf77559-e4ed-464d-b81e-d59d261e411c)

Company: https://www.globalkeysolutions.net/companies/alxigna-inc/26c48e48-4fcc-46cd-8060-afaeeb7cb42c

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c